쌀, 조, 수수 및 콩의 食餌가 흰쥐의 成長 및 血液性狀에 미치는 影響

한백수,주현규,사동민,박병순,박기웅 선문대학교 첨단과학기술연구소 1996 첨단과학기술연구소 논문집 Vol.1 No.1

쌀, 조 수수, 및 콩의 식이가 흰쥐의 성장 및 혈액 성상에 미치는 영향을 조사하기 위하여, 평균체중 180g의 Sprague-Dawley계 rat(♂) 각 5마리씩을 대조군(T_(0)), 쌀(T_(1)), 조(T_(2)), 수수(T_(3)), 콩(T_(4))급이군등 5개군으로 나누어 실온에서 6주간 사육하면서 사료섭취량, 급수량, 증체량과 6주후의 혈액상의 변화틀 조사하였다. 사료 섭취량은 대조군이 각 처리 실험군보다 높았으며 물의 급수량도 동일한 결과이었으며 그 순위는 쌀, 조, 콩, 수수 순으로 감소하였으며, 각 처리군의 증체량은 대조군 보다 낮았으며, 특히 수수는 초기보다 감소하였고, 각 처리군의 사료효율은 대조군보다 낮았으며 특히 수수처리군이 타 처리군보다 낮았다. 연액성상의 변희는 대조군에서는 큰 변화가 없으나 수수군에서 BUN, HOT지 다른군보다 높았으며 쌀의 처리군은 creatinine치가 높았고 조에서는 혈당치가 낮았으며, 콩에서는 LDH는 높았고, HGB, HCT, PI.T, RBC가 낮았고, 특히 콩 수수에서는 혈액상의 변화가 가장 컸으며 다른 실험군과 비교하였을 때 통계적인 유의성이 인정되었다. This study was conducted to investigate the effects of rice, millet, sorghum and soybean diet on the growth rate, daily intake feed ratio and change in hematology of male rats. The experimental male rats of 180g average weight were fed on control (T_(0)), rice (T_(1)), millet (T_(2)), sorghum (T_(3)) and soybean diet (T_(4)) for 6 weeks. The amount of daily feed and water intake supply in each diet group is higher than that of control group to as shown in the following order: rice, millet, soybean, sorghum. The growth ratio of each diet group is lower than that of control group. Especially, sorghum made each diet group reduce the weight even more than the initial weight. Control group is lower than each diet group in regard to the effective ratio of feed. Especially, the sorghum group is lower than other groups. Control group remained same in the change of hematology, however, sorghum group is higher than other groups for BUN, HCT. Rice group is higher in creatinine and millet group is lower in glucose content of serum than any other groups. Soybean group is higher in LDH but lower in HGB, HCT, PLT, RBC than control group. Especially, the soybean and sorghum groups showed a big change in hematology and had the statistic significance in comparison to other groups.

손익손실분석 모델개발 및 동시공학 이용에 관한 연구

백방선,한백수,강창승 한국정보전략학회 1999 추계공동학술대회 논문집 Vol.- No.01

최근 생산현장의 흐름은 우수한 품질의 제품을 출하하는 단계를 넘어서, 시장진입의 경쟁시대라고 해도 과언이 아닐 것이다. 동일한 제품을 생산하고 있는 경쟁사들은 하루라도 앞서 제품을 시장에 출하함으로써 선점권을 갖기 위해 제품개발의 초기단계에서부터 제품의 시장출하를 앞당기기 위한 경쟁은 시작되었다고 볼 수 있다. 이에 본 연구는 제품의 시장출하가 지연됨으로써 발생하는 수익의 손실을 평가해 볼 수 있는 분석모델을 수리화 하였다. 제품개발의 초기단계에서부터 제품을 생산할 수 있는 라인구축의 검토도 동시에 진행하면서 현재의 설비를 가지고 제품을 출하하는 것이 수익상 유리한지, 아니면 자본을 투자해 새로운 라인을 구축해서라도 제품의 출하시기를 앞당기는 것이 유리한지에 대한 의사결정수단을 제공한다.

화물자동차운송의 과적 차량 단속 체계 개선방안에 관한 연구

추창엽,한백수 한국물류학회 2000 물류학회지 Vol.10 No.1

The best way to eradicate the operation of overloaded vehicles is that those related to cargo transport should abide by prescribed regulations, but if they are not observed well, road managers have responsibilities and duties to preserve the road facilities constructed by the taxes of the people from a handful groups pursuing illegal profits by restricting illegal operation and imposing punishments. According to rapid economic growth since 1970s. our country has deeply recognized adverse effects of operation of overloaded vehicles starting with the activation of cargo distribution, each road manager has cracked down operation restricted vehicles, but they has not reached such extent as completely eliminate the operation of overloaded vehicles by the lack of crackdown personnel and facilities. This article aimed at draw out the problems in the existing crackdown system and presenting the reform plans to bring forth the countermeasures to eradicate the operation of overloaded vehicles in the national road.

수익손실분석 모델개발 및 동시공학 이용에 관한 연구

백방선,한백수,강창승 한국산업정보학회 1999 한국산업정보학회 학술대회논문집 Vol.1999 No.12

Pitx3 deficient mice as a genetic animal model of co-morbid depressive disorder and Parkinson's disease

김경심,김윤정,강영미,한백수,김천형,이철호,한평림,정봉현,김광수 한국실험동물학회 2012 한국실험동물학회 학술발표대회 논문집 Vol.2012 No.8

Identification of DNA Aptamers toward Epithelial Cell Adhesion Molecule via Cell-SELEX

김지원,김은영,김선용,변상경,이다솜,오경진,김원곤,한백수,지승욱,이상철,배광희 한국분자세포생물학회 2014 Molecules and cells Vol.37 No.10

The epithelial cell adhesion molecule (EpCAM, also known as CD326) is a transmembrane glycoprotein that is specifically detected in most adenocarcinomas and cancer stem cells. In this study, we performed a Cell systematic evolution of ligands by exponential enrichment (SELEX) experiment to isolate the aptamers against EpCAM. After seven round of Cell SELEX, we identified several aptamer candidates. Among the selected aptamers, EP166 specifically binds to cells expressing EpCAM with an equilibrium dissociation constant (Kd) in a micromolar range. On the other hand, it did not bind to negative control cells. Moreover, EP166 binds to J1ES cells, a mouse embryonic stem cell line. Therefore, the isolated aptamers against EpCAM could be used as a stem cell marker or in other applications in both stem cell and cancer studies.

HDAC11 Inhibits Myoblast Differentiation through Repression of MyoD-Dependent Transcription

변상경,안태현,손민정,이다솜,강현섭,이은우,한백수,김원곤,배광희,오경진,이상철 한국분자세포생물학회 2017 Molecules and cells Vol.40 No.9

Abnormal differentiation of muscle is closely associated with aging (sarcopenia) and diseases such as cancer and type II diabetes. Thus, understanding the mechanisms that regulate muscle differentiation will be useful in the treatment and prevention of these conditions. Protein lysine acetylation and methylation are major post-translational modification mecha-nisms that regulate key cellular processes. In this study, to elucidate the relationship between myogenic differentiation and protein lysine acetylation/methylation, we performed a PCR array of enzymes related to protein lysine acetylation/methylation during C2C12 myoblast differentiation. Our results indicated that the expression pattern of HDAC11 was substantially increased during myoblast differentiation. Fur-thermore, ectopic expression of HDAC11 completely inhibited myoblast differentiation, concomitant with reduced expression of key myogenic transcription factors. However, the catalytically inactive mutant of HDAC11 (H142/143A) did not impede myoblast differentiation. In addition, wild-type HDAC11, but not the inactive HDAC11 mutant, suppressed MyoD-induced promoter activities of MEF2C and MYOG (Myogenin), and reduced histone acetylation near the E-boxes, the MyoD binding site, of the MEF2C and MYOG promoters. Collectively, our results indicate that HDAC11 would suppress myoblast differentiation via regulation of MyoD-dependent transcription. These findings suggest that HDAC11 is a novel critical target for controlling myoblast differentiation.

Monitoring the Differentiation and Migration Patterns of Neural Cells Derived from Human Embryonic Stem Cells Using a Microfluidic Culture System

이나연,박재우,김형준,연주헌,권지혜,고정재,오승훈,김현숙,김애리,한백수,이상철,전누리,송지환 한국분자세포생물학회 2014 Molecules and cells Vol.37 No.6

Microfluidics can provide unique experimental tools to visualize the development of neural structures within a microscale device, which is followed by guidance of neurite growth in the axonal isolation compartment. We utilized microfluidics technology to monitor the differentiation and migration of neural cells derived from human embryonic stem cells (hESCs). We co-cultured hESCs with PA6 stromal cells, and isolated neural rosette-like structures, which subsequently formed neurospheres in suspension culture. Tuj1-positive neural cells, but not nestin- positive neural precursor cells (NPCs), were able to enter the microfluidics grooves (microchannels), suggesting that neural cell-migratory capacity was dependent upon neuronal differentiation stage. We also showed that bundles of axons formed and extended into the microchannels. Taken together, these results demonstrated that microfluidics technology can provide useful tools to study neurite outgrowth and axon guidance of neural cells, which are derived from human embryonic stem cells.

Mitochondrial transplantation: an overview of a promising therapeutic approach

Ji Soo Kim,Seonha Lee,Won-Kon Kim,한백수 생화학분자생물학회 2023 BMB Reports Vol.56 No.9

Mitochondrial transplantation is a promising therapeutic approachfor the treatment of mitochondrial diseases caused by mutationsin mitochondrial DNA, as well as several metabolic and neurologicaldisorders. Animal studies have shown that mitochondrialtransplantation can improve cellular energy metabolism, restoremitochondrial function, and prevent cell death. However,challenges need to be addressed, such as the delivery of functionalmitochondria to the correct cells in the body, and thelong-term stability and function of the transplanted mitochondria. Researchers are exploring new methods for mitochondrialtransplantation, including the use of nanoparticles or CRISPRgene editing. Mechanisms underlying the integration and functionof transplanted mitochondria are complex and not fully understood,but research has revealed some key factors that play arole. While the safety and efficacy of mitochondrial transplantationhave been investigated in animal models and human trials,more research is needed to optimize delivery methods and evaluatelong-term safety and efficacy. Clinical trials using mitochondrialtransplantation have shown mixed results, highlighting theneed for further research in this area. In conclusion, althoughmitochondrial transplantation holds significant potential for thetreatment of various diseases, more work is needed to overcomechallenges and evaluate its safety and efficacy in human trials.

Korean Mistletoe (Viscum album coloratum) Extract Improves Endurance Capacity in Mice by Stimulating Mitochondrial Activity

Hoe-Yune Jung,An-Na Lee,Tae-Jun Song,Hyo-Sun An,Young-Hoon Kim,Kyu-Dae Kim,In-Bo Kim,김경심,한백수,김천형,김광수,김종배 한국식품영양과학회 2012 Journal of medicinal food Vol.15 No.7

The beneficial effects of exercise on overall health make it desirable to identify the orally active agents that enhance the effects of exercise in an effort to cure metabolic diseases. Natural compounds such as resveratrol (RSV) are known to increase endurance by potentiating mitochondrial function. Korean mistletoe (Viscum album coloratum) extract (KME) has characteristics similar to those of RSV. In the present study, we determined whether KME could increase mitochondrial activity and exert an anti-fatigue effect. We found that KME treatment significantly increased the mitochondrial oxygen consumption rate (OCR) in L6 cells and increased the expression of peroxisome proliferator-activated receptor c coactivator (PGC)-1a and silent mating type information regulation 2 homolog 1 (SIRT1), two major regulators of mitochondria function, in C2C12 cells. In the treadmill test, KME-treated mice could run 2.5-times longer than chow-fed control mice. Additionally, plasma lactate levels of exhausted mice were significantly lower in the KME-treated group. In addition, the swimming time to exhaustion of mice treated with KME was prolonged by as much as 212% in the forced-swim test. Liver and kidney histology was similar between the KME-treated and phosphate-buffered saline-treated animals, indicating that KME was nontoxic. Taken together, our data show that KME induces mitochondrial activity, possibly by activating PGC-1a and SIRT1, and improves the endurance of mice, strongly suggesting that KME has great potential as a novel mitochondria-activating agent.